欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号MT/H/0633/002
药品名称Olanzapine PharmConsul 10 mg tablets
活性成分
    • olanzapine 10.0 mg
剂型Tablet
上市许可持有人Aurobindo Pharma (Malta) Limited, Vault 14, Level 2, Valletta Waterfront, Floriana FRN 1913, Malta
参考成员国 - 产品名称Malta (MT)
Olanzapine Aurobindo Pharma 10 mg tablets
互认成员国 - 产品名称
    • Poland (PL)
      Olanzapine PharmConsul
许可日期2023/07/10
最近更新日期2024/02/23
药物ATC编码
    • N05AH03 olanzapine
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase